SCHEMBL15046476

SCHEMBL15046476

COc1ccc(-c2cn(-c3ccc(F)cc3)c(CC(C)=O)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
SMN1; SMN2 Q16637 4/20 0.46
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
LMNA P02545 2/20 0.46
MAPK1 P28482 2/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 1/20 0.46
KMT2A Q03164 1/20 0.46
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
AGER Q15109 2/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15043866 0.92 GABRB2 (0.45) MAPTSMN1; SMN2RAB9ANPC1LMNA
SCHEMBL15033980 0.91 MAPT (0.52) MAPTSMN1; SMN2RAB9ANPC1LMNA
SCHEMBL15046452 0.90 MAPT (0.52) MAPTSMN1; SMN2RAB9ANPC1LMNA
SCHEMBL15046475 0.88 RAB9A (0.51) MAPTSMN1; SMN2RAB9ANPC1LMNA
SCHEMBL15046472 0.87 ABCB1 (0.49) MAPTSMN1; SMN2RAB9ANPC1LMNA
SCHEMBL15033992 0.87 MAPT (0.52) MAPTSMN1; SMN2RAB9ANPC1LMNA
SCHEMBL15046477 0.81 GRM5 (0.43) MAPTGABRA2GABRB2ALDH1A1
SCHEMBL15033978 0.80 GABRA2 (0.43) MAPTSMN1; SMN2LMNAGABRA2GABRB2
SCHEMBL15033985 0.80 SMN1; SMN2 (0.52) MAPTSMN1; SMN2RAB9ANPC1LMNA
SCHEMBL15046461 0.79 GABRA2 (0.42) MAPTSMN1; SMN2RAB9ALMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013087806-A1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 WO disclosed